Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ACHR vs GSK✓SelectedUSD · GSKACHR vs GSK performance historyLatest closeAs of-9.06%11/20
Stock and ETF performance explorer

ACHR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-53.4%
GSK return
+53.4%
Excess return
-106.7%
Maximum drawdown
-78.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-9.1%-0.1%-8.9%-9.1%
7D-27.8%-5.3%-22.5%-27.7%
30D-24.8%-3.7%-21.1%-24.7%
3M-52.2%-7.3%-45.0%-52.1%
6M-49.7%-4.2%-45.4%-49.7%
YTD-61.3%+0.9%-62.2%-61.5%
1Y-57.6%+7.3%-64.9%-58.2%
3Y-53.4%+52.7%-106.1%-58.6%
All-53.4%+53.4%-106.7%-58.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling